Era of ADCs: Pharma companies innovate to stand out in a buzzing market
Antibody drug conjugates (ADCs) have taken over the cancer clinical research and dealmaking landscape, with new partnerships and agreements being…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
Pharma M&A: The top high value deals in 2023
Although the pharma industry's dealmaking activity in the last 12 months has yet to surpass the peak levels seen in…
-
The top pharmaceutical companies by R&D expenditure
The year 2023 marked a significant change in the pharmaceutical industry’s landscape as investment in Covid-19 lost prominence in the…
-
The top emerging pharmaceutical companies in the US
While big pharma holds a sizable stake in the healthcare sector, several biotechs and mid-sized pharma companies fuel both the…
-
Delivery and manufacturing hurdles remain in the cell and gene therapy
The current prospects and obstacles in the cell and gene therapy space were the key focus of a panel at…
-
Delivery tech remains challenging with gene therapies for brain disorders
While the science behind specialised gene therapies continues to develop at a rapid rate, in neurodegenerative conditions the profound lack…
-
What’s next for AAV gene therapies in 2024?
Numerous FDA approvals of cell and gene therapies rendered 2023 as a landmark year for the gene therapy space. With…
-
Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs
The 2021 US approval of Novo Nordisk’s breakthrough therapy Wegovy (semaglutide) for obesity transformed the disease landscape, prompting companies to…
-
Quality and sustainability: The balancing act for pharma manufacturing
Trends in sustainability and quality assurance were key themes discussed amongst panelists at Convention on Pharmaceutical Ingredients (CPHI) Europe 2023,…
-
The future of cell and gene therapy manufacturing
The global pharmaceutical industry finds itself at a compelling intersection. The next five years will signify a critical period with…